Patient-reported symptoms and signs of moderate-to-severe psoriasis treated with guselkumab or adalimumab: Results from the randomized VOYAGE 1 trial

K A Papp, A Blauvelt, A B Kimball, C Han, B Randazzo, Y Wasfi, Y-K Shen, S Li, C E M Griffiths

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Patient-reported symptoms and signs of moderate-to-severe psoriasis treated with guselkumab or adalimumab: Results from the randomized VOYAGE 1 trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science